Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.37 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.35 |
| ▸ | TSHR | P16473 | 4/20 | 0.32 |
| ▸ | CA1 | P00915 | 2/20 | 0.32 |
| ▸ | CA2 | P00918 | 2/20 | 0.32 |
| ▸ | CA9 | Q16790 | 2/20 | 0.32 |
| ▸ | LMNA | P02545 | 2/20 | 0.32 |
| ▸ | CA12 | O43570 | 1/20 | 0.32 |
| ▸ | GLA | P06280 | 1/20 | 0.32 |
| ▸ | CA3 | P07451 | 1/20 | 0.32 |
| ▸ | CA4 | P22748 | 1/20 | 0.32 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.32 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.32 |
| ▸ | ACHE | P22303 | 1/20 | 0.32 |
| ▸ | CA7 | P43166 | 1/20 | 0.32 |
| ▸ | MMP2 | P08253 | 1/20 | 0.30 |
| ▸ | DBH | P09172 | 1/20 | 0.30 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7047121 | 0.69 | ALDH1A1 (0.40) | TDP1CYP3A4ALDH1A1TSHRCA1 | |
| SCHEMBL8957510 | 0.64 | TSHR (0.39) | TDP1ALDH1A1TSHRCA1CA2 | |
| SCHEMBL3656463 | 0.64 | ALDH1A1 (0.35) | TDP1CYP3A4ALDH1A1TSHRCA1 | |
| SCHEMBL2058398 | 0.64 | APP (0.37) | TDP1CYP3A4ALDH1A1TSHRCA1 | |
| Hydrochloric Acid SCHEMBL7156392 | 0.62 | CA4 (0.37) | TDP1CYP3A4ALDH1A1TSHRCA1 | |
| Water SCHEMBL2808996 | 0.62 | — | — | |
| Water SCHEMBL6847549 | 0.59 | ALDH1A1 (0.38) | TDP1CYP3A4ALDH1A1TSHRCA1 | |
| Phenol SCHEMBL6366351 | 0.59 | TDP1 (0.39) | TDP1CYP3A4ALDH1A1TSHRCA1 | |
| Ethyne SCHEMBL28462872 | 0.59 | — | — | |
| Water SCHEMBL6846782 | 0.59 | TDP1 (0.39) | TDP1CYP3A4ALDH1A1TSHRCA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 280 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12546063-B2 | Method for controlling decomposition of corrosion-resistant paper | NIPPON BEET SUGAR MANUFACTURING CO., LTD. (JP) | 2026-02-10 | — | — | US | claimed |
| EP-4206401-B1 | METHOD FOR CONTROLLING DECOMPOSITION OF CORROSION-RESISTANT PAPER | NIPPON BEET SUGAR MFG (JP) | 2025-09-24 | — | — | EP | claimed |
| CN-116171342-B | Decomposition control method of corrosion-resistant paper | 日本甜菜制糖株式会社 | 2024-04-30 | — | — | CN | claimed |
| US-20240026610-A1 | METHOD FOR CONTROLLING DECOMPOSITION OF CORROSION-RESISTANT PAPER | NIPPON BEET SUGAR MANUFACTURING CO., LTD. (JP) | 2024-01-25 | — | — | US | claimed |
| EP-4206401-A1 | METHOD FOR CONTROLLING DECOMPOSITION OF CORROSION-RESISTANT PAPER | Nippon Beet Sugar Manufacturing Co.,Ltd. (JP) | 2023-07-05 | — | — | EP | claimed |
| CN-116171342-A | Decomposition control method of corrosion-resistant paper | 日本甜菜制糖株式会社 | 2023-05-26 | — | — | CN | claimed |
| WO-2022044387-A1 | METHOD FOR CONTROLLING DECOMPOSITION OF CORROSION-RESISTANT PAPER | 日本甜菜製糖株式会社 | 2022-03-03 | — | — | WO | claimed |
| JP-2003524799-A | — | — | 2003-08-19 | — | — | JP | claimed |
| EP-0942329-B1 | NOVEL PROCESS FOR PREPARING RESISTS | CLARIANT FINANCE BVI LTD (VG) | 2002-11-13 | — | — | EP | claimed |
| EP-1240553-A2 | PHOTORESIST COMPOSITION FOR DEEP UV RADIATION | Clariant Finance (BVI) Limited (VG) | 2002-09-18 | — | — | EP | claimed |
| US-20010024765-A1 | Novel process for preparing resists | MERCK PATENT GMBH (DE) | 2001-09-27 | — | — | US | claimed |
| US-6284427-B1 | Process for preparing resists | CLARIANT FINANCE (BVI) LIMITED (VG) | 2001-09-04 | — | — | US | claimed |
| WO-2001042853-A2 | PHOTORESIST COMPOSITION FOR DEEP UV RADIATION | CLARIANT INTERNATIONAL LTD. (CH) | 2001-06-14 | — | — | WO | claimed |
| EP-0942329-A1 | NOVEL PROCESS FOR PREPARING RESISTS | Clariant International Ltd. (CH) | 1999-09-15 | — | — | EP | claimed |
| US-20260118767-A1 | REVERSE PATTERNING PROCESS | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2026-04-30 | — | — | US | disclosed |
| EP-4715465-A1 | MULTILAYER BODY, METHOD FOR PRODUCING MULTILAYER BODY, AND PHOTOSENSITIVE SURFACE MODIFIER | Nissan Chemical Corporation (JP) | 2026-03-25 | — | — | EP | disclosed |
| US-20260044081-A1 | COMPOSITION FOR FORMING SILICON-CONTAINING RESIST FILM AND PATTERNING PROCESS | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2026-02-12 | — | — | US | disclosed |
| US-5595855-A | PHOTORESISTS | HOECHST JAPAN LIMITED (JP) | 1997-01-21 | — | — | US | disclosed |
| US-5451343-A | Photoinitiators | SPECTRA GROUP LIMITED, INC. (US) | 1995-09-19 | — | — | US | disclosed |
| WO-1995014689-A1 | FLUORONE AND PYRONIN Y DERIVATIVES | SPECTRA GROUP LIMITED, INC. (US) | 1995-06-01 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12546063-B2 | Method for controlling decomposition of corrosion-resistant paper | MGAM, UCHL1, ME1 | TDP1 723/4885CYP3A4 1198/4885ALDH1A1 973/4885 |
| US-20260118767-A1 | REVERSE PATTERNING PROCESS | EFNA1, EPHA4, ETV6 | TDP1 3556/4885CYP3A4 3527/4885ALDH1A1 4452/4885 |
| US-20260044081-A1 | COMPOSITION FOR FORMING SILICON-CONTAINING RESIST FILM AND PATTERNING PROCESS | SMC1A, SPOUT1, LBR | TDP1 3710/4885CYP3A4 2742/4885ALDH1A1 1558/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.